A 15-valent pneumococcal conjugate vaccine ( PCV15 ) containing serotypes in PCV7 and 8 additional serotypes ( 1 , 3 , 5 , 6A , 7F , 19A , 22F , 33F ) was developed and evaluated in toddlers 12 to 15 months of age .